Internship in Innovation & Sustainability - For students in the field of Natural Sciences, Medicine or Bioengineering

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections,  where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.

The Position

 Our Global Internship Programme in Innovation & Sustainability (#IP2TIS) offers a unique opportunity for passionate individuals to gain hands-on experience in the pharmaceutical industry while making a positive impact on the world.

Are you ready to join a global network spanning 20+ countries, where bright minds collaborate to tackle real-world challenges in Innovation & Sustainability? Do you want to work on impactful projects, shape the future, and drive change from within?

In this internship, you will support a high-impact precision safety project focused on obtaining scientific input from the European Medicines Agency (EMA) on the broader application of Roche’s Precision Safety Toolbox (PST). The project combines multi-omics, advanced human cell models and AI-based analytics to better understand, predict and mitigate safety risks at the individual patient and patient-subgroup level. By contributing to this work, you will help advance a more proactive, data-driven approach to safety management in clinical development, with the goal of improving patient outcomes and reducing the burden of toxicity. Over the first 3 months, you will support the preparation and follow-up of an EMA scientific advice meeting, including key scientific documents and implementation activities. This internship also contributes to Roche’s sustainability priorities by supporting more equitable health outcomes and promoting innovative non-animal approaches in product development. It offers a unique opportunity to gain insight into cutting-edge safety science while engaging with regulatory discussions that can shape future clinical programs.

The Opportunity

• Support the preparation of a comprehensive briefing document for the EMA scientific advice meeting, outlining Roche’s proposed Precision Safety Toolbox approaches

• Contribute to the scientific and operational preparation of the EMA meeting together with internal cross-functional stakeholders

• Participate in internal discussions to help refine key scientific questions, messages and supporting evidence

• Join the EMA scientific advice meeting and contribute to the scientific discussion where appropriate

• Help capture, organize and synthesize feedback received from the regulatory interaction

• Support the development of a post-meeting implementation plan to translate EMA feedback into actionable next steps

• Contribute to the preparation of a position paper describing how the Precision Safety Toolbox can be leveraged across clinical programs

• Gain exposure to innovative approaches in precision safety, including omics, advanced in vitro models and AI-driven analytics

Who You Are

You are enrolled or have completed your Master’s, PhD or MBA studies at a university, preferably in the field of natural sciences, medicine or bioengineering within the last 12 months and are interested in applying your knowledge in a modern working environment as part of an internship of at least 3 months.

Furthermore you are

• Good understanding of biological research tools and a strong interest in translational or clinical safety science

• Strong writing, presentation and communication skills

• Fluent in English

• A collaborative team player with strong interaction and communication skills

• Adaptable and comfortable working in a dynamic, fast-changing environment

If you meet most but not all qualifications, we still encourage you to apply.

Additional information

The internship is expected to start between 1 and 16 July 2026 and will last at least 3 months.

For more information about IP2TIS and to explore other opportunities within the programme, please visit go.roche.com/ip2tis_26._ 

Who we are

A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.

Let’s build a healthier future, together.